Overview
Mentions in press and media 18
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 16, 2022 | Industry leader Paul Jones joins Vortex Biotech Holdings as new CEO | Industry leader Paul Jones joins Vortex Biotech Holdings as new CEO Tue, Aug 16, 2022 18:44 CET Report this content 16th August 2022 – VORTEX BIOTECH HOLDINGS, a leading oncology liquid biopsy company that operates at the junction of the ra... |
| Aug 16, 2022 | EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth. | EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth. Tue, Aug 16, 2022 17:04 CET Report this content London, UK, 16th August 2022 – International venture capital in... |
| May 12, 2022 | NetScientific PLC Preliminary Results for the year ended 31 December 2021 | NetScientific PLC Preliminary Results for the year ended 31 December 2021 Thu, May 12, 2022 15:01 CET Report this content Good results demonstrate excellent progress in growth strategy to realise shareholder returns NetScientific plc (AIM: ... |
| Dec 6, 2021 | NetScientific : PDS Phase 2 Clinical Trial Update | NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Phase 2 Clinical Trial Update PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Ba... |
| Nov 26, 2021 | NetScientific : $1million investment in portfolio company, EpiBone | NetScientific plc ("NetScientific", the "Group" or the "Company") $1million investment in portfolio company, EpiBone London, UK - 26 November 2021- NetScientific plc (AIM: NSCI), the international life sciences... |
| Nov 4, 2021 | Sofant Signs EUR7.3m ESA Contract | NetScientific plc ("NetScientific", the "Group" or the "Company") Sofant Signs €7.3m European Space Agency Contract London, UK - 4 November 2021- NetScientific plc (AIM: NSCI), the international life sciences a... |
| Nov 1, 2021 | PDS to License Novel Proteins for Flu Vaccine | NetScientific plc ("NetScientific", the "Group" or the "Company") PDS to License Novel Proteins for Flu Vaccine PDS Biotech Announces Agreement with University of Georgia to License Novel Proteins for Versamune... |
| Oct 26, 2021 | NetScientific : EMV Capital Participates in £843k Sofant Funding | NetScientific plc ("NetScientific", the "Group" or the "Company") EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies London, UK - 26 October 2021- N... |
| Oct 22, 2021 | NetScientific : ProAxsis announces the approval of a key US patent | NetScientific plc ("NetScientific", the "Group" or the "Company") ProAxsis announces the approval of a key US patent ProAxsis makes significant progress towards measuring bone health with a new innovation for p... |
Reviews 0
FAQ about NetScientific
When was NetScientific founded?
NetScientific was founded in 2013.
What has the press written about NetScientific?
Parsers VC has collected 18 articles mentioning NetScientific, among them “Industry leader Paul Jones joins Vortex Biotech Holdings as new CEO” (Aug 16, 2022) and “EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth.” (Aug 16, 2022).
Is NetScientific still active?
Yes, NetScientific is active; its latest activity on Parsers VC dates from Jan 13, 2023.